跳到正文
原文
NEJM· Frank C. Sciurba Henrik Watz Arnaud Bourdin Wim Janssens Fernando J. Martinez Jinping Zheng Maarten van den Berge Matteo Bonini MeiLan K. Han Dave Singh Gerard J. Criner Christopher E. Brightling Alberto Papi Surya P. Bhatt Martin Jenkins Marta Mikosz Piotr Chołbiński Monika Ziemiecka Magnus Löfdahl Deepa Arya Madhavi Yadavalli Bryan H. Brodek Malin Fagerås Samuel Bardsley Neil Martin Rajesh Patel and Ioannis Psallidasthe OBERON and TITANIA Trial Investigators*·· 24 天前评分0

Tozorakimab 预防 COPD 急性加重的疗效

Tozorakimab to Prevent COPD Exacerbations

导读

Tozorakimab 在预防慢性阻塞性肺疾病急性加重方面显示出疗效。该 III 期临床试验(NCT05507242)的顶线结果显示,与安慰剂相比,tozorakimab 治疗组的中度至重度急性加重年化率显著降低。研究达到了其主要终点。

来源:NEJM · nejm.org